HUP0100159A3 - Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition - Google Patents
Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid depositionInfo
- Publication number
- HUP0100159A3 HUP0100159A3 HU0100159A HUP0100159A HUP0100159A3 HU P0100159 A3 HUP0100159 A3 HU P0100159A3 HU 0100159 A HU0100159 A HU 0100159A HU P0100159 A HUP0100159 A HU P0100159A HU P0100159 A3 HUP0100159 A3 HU P0100159A3
- Authority
- HU
- Hungary
- Prior art keywords
- alzheimer
- disease
- prevention
- compounds
- vivo imaging
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 230000003941 amyloidogenesis Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000011503 in vivo imaging Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/10—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/968,902 US6417178B1 (en) | 1994-07-19 | 1997-11-06 | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
PCT/US1998/023598 WO1999024394A2 (en) | 1997-11-06 | 1998-11-06 | Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0100159A2 HUP0100159A2 (hu) | 2001-05-28 |
HUP0100159A3 true HUP0100159A3 (en) | 2002-09-30 |
Family
ID=25514917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0100159A HUP0100159A3 (en) | 1997-11-06 | 1998-11-06 | Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
Country Status (18)
Country | Link |
---|---|
US (1) | US6417178B1 (hu) |
EP (1) | EP1028941A2 (hu) |
JP (1) | JP2001522829A (hu) |
KR (1) | KR20010031872A (hu) |
CN (1) | CN1285818A (hu) |
AU (1) | AU1383399A (hu) |
BR (1) | BR9812776A (hu) |
CA (1) | CA2309626A1 (hu) |
EE (1) | EE200000278A (hu) |
HU (1) | HUP0100159A3 (hu) |
ID (1) | ID25797A (hu) |
IL (1) | IL135986A0 (hu) |
NO (1) | NO20002380L (hu) |
OA (1) | OA11377A (hu) |
PL (1) | PL348226A1 (hu) |
SK (1) | SK6732000A3 (hu) |
TR (1) | TR200001264T2 (hu) |
WO (1) | WO1999024394A2 (hu) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US6750324B1 (en) | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
US6787523B1 (en) | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US6761888B1 (en) | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US6913745B1 (en) | 1997-12-02 | 2005-07-05 | Neuralab Limited | Passive immunization of Alzheimer's disease |
US6923964B1 (en) | 1997-12-02 | 2005-08-02 | Neuralab Limited | Active immunization of AScr for prion disorders |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US6710226B1 (en) | 1997-12-02 | 2004-03-23 | Neuralab Limited | Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics |
US6905686B1 (en) | 1997-12-02 | 2005-06-14 | Neuralab Limited | Active immunization for treatment of alzheimer's disease |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US7179892B2 (en) * | 2000-12-06 | 2007-02-20 | Neuralab Limited | Humanized antibodies that recognize beta amyloid peptide |
US20030147882A1 (en) * | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
US6787637B1 (en) | 1999-05-28 | 2004-09-07 | Neuralab Limited | N-Terminal amyloid-β antibodies |
UA81216C2 (en) * | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
EP1266884A4 (en) * | 2000-03-22 | 2003-04-23 | Bf Res Inst Inc | IMAGE DIAGNOSIS PROBE, BASED ON SUBSTITUTED AZOBENZOL OR ITS ANALOGA, FOR DISEASES WHICH ARE ATTRIBUTED TO AMYLOID ACCUMULATION, AND MIXTURES CONTAINING THIS IMAGE |
EP2151187A1 (en) | 2000-08-21 | 2010-02-10 | The General Hospital Corporation | Methods for diagnosing a neurodegenerative condition |
US7270800B2 (en) | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
PT2264018E (pt) | 2000-08-24 | 2015-06-03 | Univ Pittsburgh | Derivados de tioflavina para uso no diagnóstico da doença de alzheimer |
US6589504B1 (en) | 2000-09-22 | 2003-07-08 | Pharmacia & Upjohn Company | Compounds and methods for diagnosing and treating amyloid-related conditions |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
TWI255272B (en) * | 2000-12-06 | 2006-05-21 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
WO2002085903A2 (en) | 2001-04-23 | 2002-10-31 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
NZ531337A (en) * | 2001-04-27 | 2006-05-26 | Gen Hospital Corp | Ocular diagnosis of alzheimer's disease |
AU2002366355A1 (en) * | 2001-12-17 | 2003-06-30 | New York State Office Of Mental Health | SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES |
US7407778B2 (en) * | 2002-02-07 | 2008-08-05 | Pettegrew Jay W | Compounds, compositions and methods for treating neuropsychiatric disorders |
US7700074B2 (en) * | 2002-02-07 | 2010-04-20 | Pettegrew Jay W | Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism |
MY139983A (en) * | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
US20050043523A1 (en) * | 2003-08-22 | 2005-02-24 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
US20040223912A1 (en) * | 2003-05-07 | 2004-11-11 | Montalto Michael Christopher | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
EP1631561B1 (en) | 2003-05-07 | 2010-08-18 | General Electric Company | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
US20060257842A1 (en) * | 2003-05-29 | 2006-11-16 | Pettegrew Jay W | Cryopreservation media and molecules |
US7815894B2 (en) * | 2003-05-29 | 2010-10-19 | Jay W. Pettegrew | Compounds, compositions and methods for medical imaging of neuropsychiatric disorders |
TWI306458B (en) | 2003-05-30 | 2009-02-21 | Elan Pharma Int Ltd | Humanized antibodies that recognize beta amyloid peptide |
US8236282B2 (en) * | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
GB0405193D0 (en) * | 2004-03-08 | 2004-04-21 | Medical Res Council | Compounds |
PE20061152A1 (es) * | 2004-12-15 | 2006-10-13 | Neuralab Ltd | Anticuerpos humanizados que reconocen el peptido beta amiloideo |
TW200635607A (en) | 2004-12-15 | 2006-10-16 | Elan Pharm Inc | Humanized Aβ antibodies for use in improving cognition |
US7957507B2 (en) | 2005-02-28 | 2011-06-07 | Cadman Patrick F | Method and apparatus for modulating a radiation beam |
US8232535B2 (en) | 2005-05-10 | 2012-07-31 | Tomotherapy Incorporated | System and method of treating a patient with radiation therapy |
WO2007014104A2 (en) | 2005-07-22 | 2007-02-01 | Tomotherapy Incorporated | System and method of evaluating dose delivered by a radiation therapy system |
US8442287B2 (en) | 2005-07-22 | 2013-05-14 | Tomotherapy Incorporated | Method and system for evaluating quality assurance criteria in delivery of a treatment plan |
CA2616304A1 (en) | 2005-07-22 | 2007-02-01 | Tomotherapy Incorporated | System and method of delivering radiation therapy to a moving region of interest |
DE602006021803D1 (de) | 2005-07-22 | 2011-06-16 | Tomotherapy Inc | System zur Verabreichung einer Strahlentherapie auf ein sich bewegendes Zielgebiet |
CN101268467B (zh) | 2005-07-22 | 2012-07-18 | 断层放疗公司 | 用于评估治疗计划的实施中的质量保证标准的方法和系统 |
WO2007014090A2 (en) | 2005-07-23 | 2007-02-01 | Tomotherapy Incorporated | Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch |
WO2007047815A2 (en) * | 2005-10-18 | 2007-04-26 | The Brigham And Women's Hospital, Inc. | Diagnosis of transmissible spongiform encephalopathy |
EP2010041A2 (en) | 2006-04-11 | 2009-01-07 | Neuroptix Corporation | Ocular imaging |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
WO2008118122A2 (en) * | 2006-05-08 | 2008-10-02 | Molecular Neuroimaging, Llc | Compounds and amyloid probes thereof for therapeutic and imaging uses |
KR100836753B1 (ko) * | 2006-09-08 | 2008-06-10 | 한국과학기술연구원 | 베타 아밀로이드 피브릴 형성 억제 화합물, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
WO2008144065A1 (en) * | 2007-05-21 | 2008-11-27 | Neuroptix Corporation | Ophthalmic formulations of amyloid- contrast agents and methods of use thereof |
ES2498040T3 (es) | 2007-07-27 | 2014-09-24 | Janssen Alzheimer Immunotherapy | Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US8389506B2 (en) * | 2007-12-07 | 2013-03-05 | Prana Biotechnology Ltd. | Compounds for therapy and diagnosis |
US20090162280A1 (en) * | 2007-12-20 | 2009-06-25 | General Electric Company | Detecting soluble a-beta |
SI2247558T1 (sl) | 2008-02-14 | 2022-07-29 | Eli Lilly And Company | Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij |
WO2009146388A1 (en) | 2008-05-28 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Voxel-based methods for assessing subjects using positron emission tomography |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
CU23844B1 (es) | 2009-04-17 | 2012-10-15 | Ct De Neurociencias De Cuba | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
EP2530464A1 (en) * | 2010-01-28 | 2012-12-05 | Panasonic Corporation | Amyloid measurement method |
EP2368558A1 (en) | 2010-03-23 | 2011-09-28 | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
KR101905436B1 (ko) | 2010-08-16 | 2018-10-08 | 코그놉틱스, 인코포레이티드 | 아밀로이드 단백질을 검출하기 위한 시스템 및 방법 |
BR112015007095A8 (pt) | 2012-09-28 | 2019-08-20 | Warner Babcock Inst For Green Chemistry Llc | derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados, composição farmacêutica compreendendoos e uso dos referidos derivados |
JP6412020B2 (ja) | 2013-02-26 | 2018-10-24 | アキュレイ インコーポレイテッド | 電磁作動式のマルチリーフコリメーター |
AR098232A1 (es) | 2013-10-31 | 2016-05-18 | Cognoptix Inc | Métodos de preparación de una formulación oftálmica y usos de la misma |
WO2020006357A1 (en) * | 2018-06-29 | 2020-01-02 | Tets Viktor Veniaminovich | Methods for diagnosis and treatment of type 1 diabetes |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US476336A (en) * | 1892-06-07 | Fabriken | ||
US401024A (en) * | 1889-04-09 | Benfabriken | ||
US464775A (en) * | 1891-12-08 | Ors to tfie farbenfabrikek | ||
US1314926A (en) * | 1919-09-02 | Chester e | ||
US2472965A (en) * | 1949-06-14 | Metallized tetrakisazo dyes | ||
US410057A (en) * | 1889-08-27 | Liams | ||
US493413A (en) * | 1893-03-14 | Bruno richard seifert | ||
US394841A (en) * | 1888-12-18 | Carl duisberg | ||
US718028A (en) * | 1900-11-06 | 1903-01-06 | Basf Ag | Mixed disazo dye and process of making same. |
US888522A (en) * | 1908-02-01 | 1908-05-26 | Farbenfab Vorm Bayer F & Co | Red tetrazo dye. |
US964920A (en) * | 1910-04-13 | 1910-07-19 | Corp Chem Fab Griesheim Elektron | Disazo dye. |
US982509A (en) * | 1910-07-15 | 1911-01-24 | Griesheim Elektron Chem Fab | Disazo dyestuff. |
US995161A (en) * | 1910-12-13 | 1911-06-13 | Griesheim Elektron Chem Fab | Disazo dyes for wool. |
US1784343A (en) * | 1922-08-17 | 1930-12-09 | Gen Aniline Works Inc | Lew azo dyestuffs |
US1660625A (en) * | 1926-03-24 | 1928-02-28 | Grasselli Dyestuff Corp | Mordant disazo dyestuffs |
DE454177C (de) | 1926-03-25 | 1927-12-30 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von beizenziehenden Azofarbstoffen |
US1757500A (en) * | 1926-12-10 | 1930-05-06 | British Dyestuffs Corp Ltd | Relating to manufacture of new secondary disazo dyes from 1:8-aminonaphthol sulphonic acid |
NL32376C (hu) * | 1931-09-28 | |||
US2012779A (en) * | 1933-03-31 | 1935-08-27 | Chem Ind Basel | Chromiferous azo-dyestuff and process of making same |
US2314023A (en) * | 1939-08-08 | 1943-03-16 | Chem Ind Basel | Substantive azo dyestuffs and process of making same |
US2367053A (en) * | 1941-09-06 | 1945-01-09 | Du Pont | Disazo dyestuffs |
US2803625A (en) * | 1951-11-15 | 1957-08-20 | Bayer Ag | Chromium complex disazo dyestuffs |
US2773864A (en) * | 1952-04-19 | 1956-12-11 | Gen Aniline & Film Corp | Coupling assistants for polyazo dyes |
US2912428A (en) | 1956-03-07 | 1959-11-10 | Ciba Ltd | Process for the manufacture of azo pigments |
US2954371A (en) * | 1958-02-12 | 1960-09-27 | Ciba Ltd | Water insoluble disazo-dyestuffs |
NL258787A (hu) * | 1959-04-16 | |||
GB1028567A (en) * | 1962-08-14 | 1966-05-04 | Sumitomo Chemical Co | Improvements in or relating to disazo dyestuffs |
NL130680C (hu) * | 1965-04-29 | |||
US3485814A (en) * | 1965-08-12 | 1969-12-23 | Du Pont | Disazo sulfonic acid dyes |
FR2036652A5 (en) | 1969-03-06 | 1970-12-24 | Ciba Geigy | Naphthoxazole optical blueing agents |
CH553807A (de) | 1970-12-23 | 1974-09-13 | Sandoz Ag | Verfahren zur herstellung von dibenzthiophendioxidderivaten. |
JPS547814B2 (hu) | 1971-09-16 | 1979-04-10 | ||
DE2251703A1 (de) * | 1972-10-21 | 1974-05-02 | Hoechst Ag | Verfahren zum faerben von synthetischen fasermaterialien aus organischen loesemitteln |
DE2256171C3 (de) | 1972-11-16 | 1979-07-26 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von Disazopigmenten |
JPS5516573B2 (hu) | 1972-11-16 | 1980-05-02 | ||
US4006131A (en) * | 1973-01-04 | 1977-02-01 | Sandoz Ltd. | Anionic disazo dyes having a 2,2'-dihalodiphenyl tetrazo component radical |
JPS5817158A (ja) | 1981-07-23 | 1983-02-01 | Dainippon Ink & Chem Inc | 紫外線を遮断する樹脂組成物 |
US4933156A (en) * | 1987-04-08 | 1990-06-12 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
DE3725082A1 (de) * | 1987-07-29 | 1989-02-09 | Bayer Ag | Disazofarbstoffe |
US6168776B1 (en) * | 1994-07-19 | 2001-01-02 | University Of Pittsburgh | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
ES2149945T3 (es) * | 1994-12-12 | 2000-11-16 | Ciba Sc Holding Ag | Colorantes azoicos, procedimiento de obtencion y utilizacion de los mismos. |
CA2219880A1 (en) | 1995-05-01 | 1996-11-07 | University Of Pittsburgh | Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
-
1997
- 1997-11-06 US US08/968,902 patent/US6417178B1/en not_active Expired - Fee Related
-
1998
- 1998-11-06 JP JP2000520408A patent/JP2001522829A/ja active Pending
- 1998-11-06 SK SK673-2000A patent/SK6732000A3/sk unknown
- 1998-11-06 HU HU0100159A patent/HUP0100159A3/hu unknown
- 1998-11-06 EE EEP200000278A patent/EE200000278A/xx unknown
- 1998-11-06 WO PCT/US1998/023598 patent/WO1999024394A2/en not_active Application Discontinuation
- 1998-11-06 TR TR2000/01264T patent/TR200001264T2/xx unknown
- 1998-11-06 EP EP98957613A patent/EP1028941A2/en not_active Withdrawn
- 1998-11-06 CA CA002309626A patent/CA2309626A1/en not_active Abandoned
- 1998-11-06 IL IL13598698A patent/IL135986A0/xx unknown
- 1998-11-06 CN CN98812963A patent/CN1285818A/zh active Pending
- 1998-11-06 PL PL98348226A patent/PL348226A1/xx unknown
- 1998-11-06 KR KR1020007004950A patent/KR20010031872A/ko not_active Application Discontinuation
- 1998-11-06 BR BR9812776-4A patent/BR9812776A/pt not_active IP Right Cessation
- 1998-11-06 ID IDW20001067D patent/ID25797A/id unknown
- 1998-11-06 AU AU13833/99A patent/AU1383399A/en not_active Abandoned
-
2000
- 2000-05-05 OA OA1200000134A patent/OA11377A/en unknown
- 2000-05-05 NO NO20002380A patent/NO20002380L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1383399A (en) | 1999-05-31 |
CN1285818A (zh) | 2001-02-28 |
BR9812776A (pt) | 2003-06-10 |
KR20010031872A (ko) | 2001-04-16 |
US6417178B1 (en) | 2002-07-09 |
TR200001264T2 (tr) | 2001-08-21 |
EP1028941A2 (en) | 2000-08-23 |
CA2309626A1 (en) | 1999-05-20 |
HUP0100159A2 (hu) | 2001-05-28 |
JP2001522829A (ja) | 2001-11-20 |
WO1999024394A9 (en) | 2001-05-31 |
ID25797A (id) | 2000-11-02 |
WO1999024394A3 (en) | 1999-08-19 |
NO20002380L (no) | 2000-07-04 |
NO20002380D0 (no) | 2000-05-05 |
SK6732000A3 (en) | 2002-05-09 |
EE200000278A (et) | 2001-08-15 |
OA11377A (en) | 2004-01-28 |
WO1999024394A2 (en) | 1999-05-20 |
PL348226A1 (en) | 2002-05-06 |
IL135986A0 (en) | 2001-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100159A3 (en) | Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | |
ZA983301B (en) | Alkyl alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition. | |
AU8670201A (en) | Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | |
HUP0103838A3 (en) | Alzheimer's disease secretase | |
HK1078468A1 (en) | Diagnostic imaging contrast agents with extended blood retention | |
EP1043991A4 (en) | TREATMENT OF ALZHEIMER DISEASE | |
EP0808324A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CARDIOVASCULAR DISEASES | |
IL105216A0 (en) | Method and kit for the diagnosis of alzheimer's disease | |
HUP9900426A3 (en) | Amyloid binding azoderivatives, preparation thereof and use of these compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | |
EP0906573A4 (en) | METHODS FOR DIAGNOSING THE CLINICAL SUBTYPES OF MORBUS CROHN. | |
EP1007048A4 (en) | IDENTIFICATION OF AGENTS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
AP2001002102A0 (en) | Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas | |
AU7556994A (en) | Methods for the diagnosis of alzheimer's disease | |
EP0975651A4 (en) | TRANSGENIC ANIMALS AND CELL LINES FOR THE SCREENING OF MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE | |
NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
HUP0003684A3 (en) | Diagnostic test for alzheimer's disease | |
AU5153398A (en) | Diagnostic method for the detection of alzheimer's disease in living patients | |
IL117695A0 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
AU5550800A (en) | Diagnosis and treatment of alzheimer's disease | |
GB9825948D0 (en) | Diagnosis of spongiform disease | |
GB9323826D0 (en) | Diagnosis of alzheimer's disease | |
NZ319260A (en) | Method for the diagnosis of coeliac disease | |
GB9717142D0 (en) | Diagnosis of alzheimer's disease | |
GB9418854D0 (en) | Diagnosis of alzheimer's disease | |
GB9517266D0 (en) | Diagnosis of alzheimer's disease |